Shiga Microalbuminuria Reduction Trial-2
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 237 participants.
Also called NCT01461499
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 237 participants
- Sponsor
- Shiga University
- Registry
-
NCT01461499
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01461499. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2018-02-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shiga Microalbuminuria Reduction Trial-2
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Hypertension
- Intervention (Drug)
- Aliskiren
- Intervention (Drug)
- any angiotensin receptor blockers
- Lead sponsor
- Shiga University
Record details
- Record id
cardio:ct-nct01461499- Content hash
aad6caa7c4a6ea70477db369a1da4a27e3731a8b38ebef92597279361ace76c0